These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 23617506
21. JOURNAL CLUB: Is screening MRI indicated for women with a personal history of breast cancer? Analysis based on biopsy results. Arazi-Kleinman T, Skair-Levy M, Slonimsky E, Maly B, Uziely B, Libson E, Sella T. AJR Am J Roentgenol; 2013 Oct; 201(4):919-27. PubMed ID: 24059385 [Abstract] [Full Text] [Related]
22. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. Liberman L, Holland AE, Marjan D, Murray MP, Bartella L, Morris EA, Dershaw DD, Wynn RT. AJR Am J Roentgenol; 2007 Mar; 188(3):684-90. PubMed ID: 17312054 [Abstract] [Full Text] [Related]
23. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound. Pediconi F, Catalano C, Roselli A, Dominelli V, Cagioli S, Karatasiou A, Pronio A, Kirchin MA, Passariello R. Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554 [Abstract] [Full Text] [Related]
24. Prediction of Residual Malignancy After Excisional Biopsy for Breast Cancer With Suspicious Microcalcifications: Comparison of Mammography and Magnetic Resonance Imaging. Park G, Bae K, Hwang IY, Kim JS, Kwon WJ, Bang M. Clin Breast Cancer; 2019 Dec; 19(6):e753-e758. PubMed ID: 31182403 [Abstract] [Full Text] [Related]
25. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population? Arazi-Kleinman T, Causer PA, Jong RA, Hill K, Warner E. Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125 [Abstract] [Full Text] [Related]
26. Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patients. Choi HK, Cho N, Moon WK, Im SA, Han W, Noh DY. Eur J Radiol; 2012 Apr; 81(4):737-43. PubMed ID: 21300498 [Abstract] [Full Text] [Related]
27. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization. Wallace AM, Daniel BL, Jeffrey SS, Birdwell RL, Nowels KW, Dirbas FM, Schraedley-Desmond P, Ikeda DM. J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466 [Abstract] [Full Text] [Related]
28. Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI. Kim HJ, Im YH, Han BK, Choi N, Lee J, Kim JH, Choi YL, Ahn JS, Nam SJ, Park YS, Choe YH, Ko YH, Yang JH. Acta Oncol; 2007 Apr; 46(7):996-1003. PubMed ID: 17851879 [Abstract] [Full Text] [Related]
29. Effectiveness of dynamic MRI for diagnosing pericicatricial minimal residual breast cancer following excisional biopsy. Kawashima H, Tawara M, Suzuki M, Matsui O, Kadoya M. Eur J Radiol; 2001 Oct; 40(1):2-9. PubMed ID: 11673001 [Abstract] [Full Text] [Related]
30. The negative predictive value of breast Magnetic Resonance Imaging in noncalcified BIRADS 3 lesions. Dorrius MD, Pijnappel RM, Sijens PE, van der Weide MC, Oudkerk M. Eur J Radiol; 2012 Feb; 81(2):209-13. PubMed ID: 21251784 [Abstract] [Full Text] [Related]
31. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T. Lo GG, Ai V, Chan JK, Li KW, Cheung PS, Wong TT, Ma M, Lee R, Chien D. J Comput Assist Tomogr; 2009 Feb; 33(1):63-9. PubMed ID: 19188787 [Abstract] [Full Text] [Related]
32. Prognostic value DCE-MRI parameters in predicting factor disease free survival and overall survival for breast cancer patients. Tuncbilek N, Tokatli F, Altaner S, Sezer A, Türe M, Omurlu IK, Temizoz O. Eur J Radiol; 2012 May; 81(5):863-7. PubMed ID: 21398061 [Abstract] [Full Text] [Related]
33. Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions. Gutierrez RL, Demartini WB, Eby P, Kurland BF, Peacock S, Lehman CD. Acad Radiol; 2009 Oct; 16(10):1281-5. PubMed ID: 19733804 [Abstract] [Full Text] [Related]
35. Assessment of suspected breast cancer by MRI: a prospective clinical trial using a combined kinetic and morphologic analysis. Wiener JI, Schilling KJ, Adami C, Obuchowski NA. AJR Am J Roentgenol; 2005 Mar; 184(3):878-86. PubMed ID: 15728612 [Abstract] [Full Text] [Related]
36. Does magnetic resonance imaging accurately predict residual disease in breast cancer? Stucky CC, McLaughlin SA, Dueck AC, Gray RJ, Giurescu ME, Carpenter SG, Grimsby GM, Apsey HA, Pockaj BA. Am J Surg; 2009 Oct; 198(4):547-52. PubMed ID: 19800466 [Abstract] [Full Text] [Related]
37. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement. Carbonaro LA, Verardi N, Di Leo G, Sardanelli F. Invest Radiol; 2010 Mar; 45(3):114-20. PubMed ID: 20065856 [Abstract] [Full Text] [Related]
38. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? Linda A, Zuiani C, Furlan A, Lorenzon M, Londero V, Girometti R, Bazzocchi M. AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168 [Abstract] [Full Text] [Related]
39. Diagnostic value of dynamic contrast medium enhanced magnetic resonance imaging in preoperative detection of thyroid carcinoma. Tezelman S, Giles Y, Tunca F, Gok K, Poyanli A, Salmaslioglu A, Terzioglu T. Arch Surg; 2007 Nov; 142(11):1036-41. PubMed ID: 18025330 [Abstract] [Full Text] [Related]
40. High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging. Gutierrez RL, DeMartini WB, Silbergeld JJ, Eby PR, Peacock S, Javid SH, Lehman CD. AJR Am J Roentgenol; 2011 Jan; 196(1):W93-9. PubMed ID: 21178040 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]